Impact of CYP2D6 polymorphisms on clinical efficacy & tolerability of metoprolol tartrate

Metoprolol is a selective β-1 adrenergic receptor blocker that undergoes extensive metabolism by the polymorphic enzyme, CYP2D6. Our objective was to investigate the influence of CYP2D6 polymorphisms on efficacy and tolerability of metoprolol tartrate. 281 study participants with uncomplicated hyper...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hamadeh, Issam S., Langaee, Taimour Y., Dwivedi, Ruti, Garcia, Sofia, Burkley, Ben M., Chapman, Arlene B., Gums, John G., Turner, Stephen T., Gong, Yan, Cooper-DeHoff, Rhonda M., Johnson, Julie A.
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4111800/
https://ncbi.nlm.nih.gov/pubmed/24637943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2014.62
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars